IHT Wealth Management’s Precision BioSciences DTIL Stock Holding History

IHT Wealth Management’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-438	Closed	-$21K	–	879
2022 Q2	$21K	Hold	438	–	–	﹤0.01%	722
2022 Q1	$40K	Hold	438	–	–	﹤0.01%	745
2021 Q4	$97K	Hold	438	–	–	0.01%	778
2021 Q3	$152K	Buy	438 +5	+1%	+$1.69K	0.01%	760
2021 Q2	$163K	Sell	433 -13	-3%	-$3.9K	0.01%	892
2021 Q1	$138K	Buy	446 +28	+7%	+$9.8K	0.01%	798
2020 Q4	$104K	Sell	418 -10	-2%	-$2.45K	0.01%	716
2020 Q3	$79K	Hold	428	–	–	0.01%	643
2020 Q2	$107K	Hold	428	–	–	0.01%	556
2020 Q1	$77K	Buy	428 +76	+22%	+$19.9K	0.01%	520
2019 Q4	$147K	Sell	352 -16	-4%	-$5.03K	0.02%	585
2019 Q3	$93K	Buy	+368	New	+$120K	0.01%	587

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

IHT Wealth Management's DTIL Position: Q3 2022 in Review

IHT Wealth Management sold out of Precision BioSciences (DTIL) in Q3 2022, closing a stake of 438 shares — an estimated $21K sold.

IHT Wealth Management first reported a position in DTIL in Q3 2019 and held it in 12 quarters. The position peaked at $163K in Q2 2021. 102 funds tracked by Wall St. Rank hold DTIL as of Q3 2022.

IHT Wealth Management reported no remaining Precision BioSciences position as of Q3 2022 after selling out during the quarter.
IHT Wealth Management sold 438 Precision BioSciences shares in Q3 2022, an estimated $21K.
IHT Wealth Management first reported a position in Precision BioSciences in Q3 2019 and held it in 12 quarters.
IHT Wealth Management's Precision BioSciences position peaked at $163K in Q2 2021.
102 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2022.

Based on IHT Wealth Management's 13F filing for Q3 2022, filed 22 Nov 2022.